$ALNY · Alnylam Pharmaceuticals, Inc. Congress Trades

Hon. Josh Gottheimer conducted extensive trading activity in January 2024 across a diversified portfolio of 40+ stocks, including purchases and sales of technology (MSFT, AAPL, TSLA, AMD), semiconductors (LRCX, ON), pharmaceuticals (AGIO, ALNY), and international securities, with all transactions in the $1,001-$15,000 range, executed through a Morgan Stanley Select UMA Account.

Rep. Josh Gottheimer (NJ-05) executed 47 transactions in December 2023 through his Morgan Stanley Select UMA Account, consisting primarily of sales and purchases of individual stocks and ADRs across technology, healthcare, energy, and international sectors, with transaction amounts ranging from $1,001-$15,000 each, except for one larger purchase of Northrop Grumman (NOC) valued at $15,001-$50,000.

Rep. Josh Gottheimer (NJ-05) executed 26 transactions in September 2022, primarily selling partial positions across a diversified portfolio including technology stocks (NVDA, ORCL, CRM, MDB), healthcare/pharma stocks (REGN, UNH, ALNY), and industrial/financial holdings (BX, DE, HCA), with a few purchases in Flywire, Regeneron, UnitedHealth, Shimano ADR, and Stag Industrial. All transactions were in the $1,001-$15,000 range and conducted through Morgan Stanley's Select UMA Account.

Rep. Josh Gottheimer (NJ-05) executed approximately 60 transactions in November 2020 across a diverse portfolio managed by Morgan Stanley, including significant options activity in Microsoft (purchasing and selling call options ranging from $100,001 to $1,000,000) and numerous stock purchases and sales in tech and growth stocks (including Tesla, Netflix, Nvidia, Facebook, and others) valued between $1,001-$15,000 each.